Market Overview:

The Enteric Softgel Capsules Market is experiencing steady expansion, driven by Growing Prevalence of Chronic Diseases, Increasing Preference Toward Nutritional Supplements and Rising Geriatric Population. According to IMARC Group's latest research publication, "Enteric Softgel Capsules Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", offers a comprehensive analysis of the industry, which comprises insights on the global enteric softgel capsules market share. The market size reached USD 2.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.7 Billion by 2033, exhibiting a growth rate (CAGR) of 3.6% during 2025-2033.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers  and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

Download a sample PDF of this report: : https://www.imarcgroup.com/enteric-softgel-capsules-market/requestsample

Our Report Includes:

• Market Dynamics
• Market Trends and Outlook
• Competitive Analysis
• Industry Segmentation
• Strategic Recommendations

Growth Factors in the Enteric Softgel Capsules Industry:

• Growing Prevalence of Chronic Diseases

The enteric softgel capsule market growth is significantly driven by the rising prevalence of chronic diseases like diabetes, cardiovascular disease, and gastrointestinal disorders. As per Centers of Diseases Control and Prevention, an estimated 129 million people in the US have at least 1 major chronic disease including heart disease, cancer, diabetes, obesity, and hypertension. Besides, five of the top 10 leading causes of death in the US are, or are strongly associated with, preventable and treatable chronic diseases. Enteric softgel capsules offer a continuous and targeted release of medication, which is beneficial for treating illnesses that often require long-term treatment. By releasing its contents in the intestines instead of the stomach, these capsules make sure the medication is absorbed where it works best. This targeted administration is a desirable alternative for managing chronic diseases since it can enhance therapeutic outcomes and lessen side effects.

• Increasing Preference Toward Nutritional Supplements

Another factor propelling the enteric softgel capsule market revenue is the growing inclination of consumers toward dietary supplements. As per the National Library of Medicine, the global nutraceuticals and supplements market has steadily grown over the past decade and was reported to be worth $353 Billion in 2019. Research in the field has also grown, with over 70,000 published articles available in PubMed relating to nutraceuticals or dietary supplements respectively. The occurrence of the coronavirus disease (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) starting in November 2019 led to an even greater increase in sales of dietary supplements and nutraceuticals in early 2020. The nutraceutical sector uses enteric softgel capsules extensively to provide vitamins, minerals, and other nutritional supplements.

• Rising Geriatric Population

Another major aspect increasing the enteric softgel capsule market value is the growing geriatric population. According to the United Nations (UN), the global population aged 65 years or older is expected to be more than double, increasing from 761 million in 2021 to 1.6 billion by 2050. The population aged 80 years or older is growing at an even faster rate. Elderly people frequently have particular healthcare demands, such as managing several chronic illnesses and requiring easy-to-swallow, gastrointestinal-friendly drugs. These criteria are met by enteric softgel capsules, which provide a practical and efficient method of delivering prescription drugs and dietary supplements. These capsules' enteric coating is especially helpful as digestive problems are more common in the elderly population.

Key Trends in the Enteric Softgel Capsules Market:

• Growing Demand for Plant-Based and Vegan Alternatives

The market is witnessing increased demand for non-gelatin softgel capsules made from plant-based materials to cater to vegan and vegetarian consumers. Manufacturers are developing enteric softgel capsules using cellulose-based and other plant-derived materials that offer similar protective benefits while aligning with dietary preferences and ethical considerations. This trend is driven by growing consumer awareness about animal welfare and environmental sustainability, prompting companies to innovate in alternative capsule materials.

• Enhanced Bioavailability Formulations

There is a growing focus on developing enteric softgel capsules with enhanced bioavailability characteristics that improve nutrient absorption and therapeutic effectiveness. Advanced formulation technologies are being employed to optimize the release profiles of active ingredients, ensuring maximum absorption in the intestines. These improvements are particularly valuable for delivering sensitive compounds like probiotics, omega-3 fatty acids, and fat-soluble vitamins that benefit from targeted intestinal release.

• E-Commerce and Online Distribution Expansion

The digital transformation of retail is significantly impacting the distribution landscape for enteric softgel capsules. Online stores and e-commerce platforms are experiencing rapid growth as consumers increasingly prefer the convenience of purchasing health supplements and pharmaceuticals online. This trend is supported by improved logistics, wider product selection, detailed product information availability, and competitive pricing on digital platforms, making health products more accessible to consumers globally.

Leading Companies Operating in the Global Enteric Softgel Capsules Industry:

• Aenova Group GmbH
• BASF SE
• Catalent, Inc.
• Colorcon Inc.
• Fuji Capsule Co., Ltd.
• Lonza Group AG
• Now Health Group, Inc.
• ProCaps Group
• Super Spectrim
• Thermo Fisher Scientific, Inc.

Enteric Softgel Capsules Market Report Segmentation:

Breakup by Type:

• Gelatin Capsules
• Non-Gelatin Softgel Capsules

Gelatin capsules accounts for the majority of the market share due to their exceptional biocompatibility, easy absorption, and high bioavailability derived from animal collagen as a natural protein.

Breakup by Application:

• Health Supplements
• Pharmaceuticals

Health supplements hold the largest share of the industry due to increasing awareness of maintaining general health and wellbeing, with consumers seeking supplements that boost immunity and deliver vital nutrients.

Breakup by Distribution Channel:

• Supermarkets and Hypermarkets
• Pharmacy and Drug Stores
• Online Stores

Pharmacy and drug stores represent the leading market segment as these widely dispersed retail locations offer convenient points of sale with expert pharmacist guidance for health-related products.

Breakup by Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America leads the market, accounting for the largest enteric softgel capsules market share driven by increasing prevalence of chronic disorders, aging populations, and demand for efficient drug delivery methods.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States:+1-201971-6302